We only have this paper's title and publication details.
Read it at the sourceCorrigendum addresses findings on how epigallocatechin-3-gallate impacts myocardial injury in diabetes, suggesting significant therapeutic potential.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: